Your shopping cart is currently empty

Wnt/β-catenin-IN-2 (Compound 3235-0367) serves as an inhibitor of the Wnt/β-catenin signaling pathway, exhibiting IC50 and KD values of 7.1 and 2.5 μM, respectively. It is applicable in cancer research [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | Wnt/β-catenin-IN-2 (Compound 3235-0367) serves as an inhibitor of the Wnt/β-catenin signaling pathway, exhibiting IC50 and KD values of 7.1 and 2.5 μM, respectively. It is applicable in cancer research [1]. |
| In vitro | Wnt/β-catenin-IN-2 inhibits Wnt3a-induced β signaling in 3T3 cells in a dose-dependent manner within the low micromolar range (0-40 μM, 12-16 h) [1]. Additionally, it suppresses LRP6 phosphorylation induced by Wnt signaling in Wnt3a-treated HEK293T cells at 10 μM for 3 hours [1]. |
| Molecular Weight | 518.56 |
| Formula | C28H30N4O6 |
| Cas No. | 1397006-01-7 |
| Smiles | N(C(=O)C1=CC=C(OC)C=C1)C2=C(C(NC(C(NNC(COC3=CC=CC=C3)=O)=O)C(C)C)=O)C=CC=C2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.